Zydus Lifesciences Stock Forecast for 2023 - 2025 - 2030
Updated on 03/29/2024
Zydus Lifesciences Stock Forecast and Price Target
In recent months, Twenty two notable analysts have provided yearlong price targets for Zydus Lifesciences, with the average target coming in at Rp840.00. If it were to be achieved, this would result in a potential downside of approximately -15.53 percent from the most recent closing price in March, 2024. The high end is Rp1107.00, and the low is Rp550.00. If interested in ZYDUSLIFE stock, you may also want to consider its competitors.
-15.53% Downside
Zydus Lifesciences Fair Value Forecast for 2023 - 2025 - 2030
Zydus Lifesciences's Price has grown in the last three years, jumping from Rp278.46 to Rp466.83 – an increase of 67.65%. In the next year, analysts predict that Fair Value will reach Rp596.12 – an increase of 27.69%. For the next seven years, the forecast is for Fair Value to grow by 36.38%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$734.37 | Buy/Sell | $636.99 | 10.71% |
MRK Stock Forecast | Merck | Outperform |
2
|
$122.77 | Buy/Sell | $130.51 | 9.96% |
ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$120.19 | Buy/Sell | $118.92 | 4.83% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.37 | Buy/Sell | $32.87 | 10.82% |
SAN Stock Forecast | Sanofi | Outperform |
16
|
88.32€ | Buy/Sell | 102.80€ | 21.15% |
Zydus Lifesciences Revenue Forecast for 2023 - 2025 - 2030
Zydus Lifesciences's Revenue has grown in the last three years, jumping from Rp142.53B to Rp172.37B – an increase of 20.94%. In the next year, analysts predict that Revenue will reach Rp191.10B – an increase of 10.86%. For the next seven years, the forecast is for Revenue to grow by 26.76%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GSK Stock Forecast | GSK | Outperform |
12
|
£16.75 | Buy/Sell | £17.30 | 11.04% |
ZTS Stock Forecast | Zoetis | Outperform |
18
|
$183.49 | Buy/Sell | $220.47 | 20.72% |
SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.59k | Buy/Sell | Rp1.52k | -1.42% |
Zydus Lifesciences Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Zydus Lifesciences's Dividend per Share has increased by 71.43%, going from Rp3.50 to Rp6.00. According to 23 major analysts, Zydus Lifesciences's Dividend per Share will fall by 12.50% in the next year, reaching Rp5.25. Professionals believe that By 2030, Zydus Lifesciences's Dividend per Share will fall to Rp5.79– a 3.48% decrease from its current value.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BAYN Stock Forecast | Bayer | Hold |
5
|
26.82€ | Buy/Sell | 45.15€ | 26.77% |
TEVA Stock Forecast | Teva Pharmaceutical Industries | Outperform |
12
|
$13.35 | Buy/Sell | $11.59 | 19.85% |
CIPLA Stock Forecast | Cipla | Outperform |
18
|
Rp1.50k | Buy/Sell | Rp1.43k | -1.93% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.97 | Buy/Sell | $11.73 | 0.25% |
500124 Stock Forecast | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.38k | Buy/Sell | Rp5.67k | -6.20% |
500420 Stock Forecast | Torrent Pharmaceuticals | Outperform |
18
|
Rp2.70k | Buy/Sell | Rp2.13k | 3.82% |
Zydus Lifesciences EBITDA Forecast for 2023 - 2025 - 2030
Zydus Lifesciences's EBITDA has increased by 28.05% In the last three years, going from Rp27.60B to Rp35.34B. In the next year, analysts expect EBITDA to reach Rp46.91B – an increase of 32.73%. For the next seven years, the forecast is for EBITDA to grow by 42.20%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
APOLLOHOSP Stock Forecast | Apollo Hospitals Enterprise | Outperform |
18
|
Rp6.20k | Buy/Sell | Rp6.91k | 15.89% |
500257 Stock Forecast | Lupin | Hold |
12
|
Rp1.67k | Buy/Sell | Rp1.11k | -8.05% |
ELAN Stock Forecast | Elanco Animal Health | Outperform |
13
|
$16.02 | Buy/Sell | $14.90 | 12.36% |
Zydus Lifesciences EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Zydus Lifesciences's EBIT has grown, increasing from Rp21.02B to Rp28.53B – a growth of 35.74%. The next year looks promising for Zydus Lifesciences, with analysts predicting EBIT of Rp39.88B – an increase of 39.79%. Over the next seven years, experts anticipate that Zydus Lifesciences's EBIT will grow at a rate of 46.73%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
500488 Stock Forecast | Abbott India | Outperform |
18
|
Rp27.23k | Buy/Sell | Rp24.75k | 5.19% |
AUROPHARMA Stock Forecast | Aurobindo Pharma | Outperform |
18
|
Rp1.06k | Buy/Sell | Rp1.09k | 10.08% |
HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.10 | Buy/Sell | £28.11 | 55.34% |
Zydus Lifesciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
Zydus Lifesciences's EPS has grown in the last three years, jumping from Rp14.28 to Rp23.94 – an increase of 67.65%. In the next year, analysts predict that EPS will reach Rp30.57 – an increase of 27.69%. For the next seven years, the forecast is for EPS to grow by 36.38%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
500660 Stock Forecast | GlaxoSmithKline Pharmaceutical... | Hold |
18
|
Rp2.01k | Buy/Sell | Rp1.78k | 5.21% |
BIOCON Stock Forecast | Biocon | Hold |
14
|
Rp279.20 | Buy/Sell | Rp270.86 | 2.08% |
VIRP Stock Forecast | Virbac | Outperform |
18
|
342.00€ | Buy/Sell | 347.01€ | 2.05% |